Department of Nuclear Medicine, University of Wuerzburg, Oberdürrbacher Str, 6, Wuerzburg, D-97080, Germany.
EJNMMI Res. 2012 Sep 27;2(1):52. doi: 10.1186/2191-219X-2-52.
BACKGROUND: Ga-[1,4,7,10-tetraazacyclododecane-N,N',N″,N'″-tetraacetic acid]-d-Phe1,Tyr3-octreotate (DOTATATE) positron emission tomography (PET) is commonly used for the visualization of somatostatin receptor (SSTR)-positive neuroendocrine tumors. SSTR is also known to be expressed on macrophages, which play a major role in inflammatory processes in the walls of coronary arteries and large vessels. Therefore, imaging SSTR expression has the potential to visualize vulnerable plaques. We assessed 68Ga-DOTATATE accumulation in large vessels in comparison to 18F-2-fluorodeoxyglucose (FDG) uptake, calcified plaques (CPs), and cardiovascular risk factors. METHODS: Sixteen consecutive patients with neuroendocrine tumors or thyroid cancer underwent both 68Ga-DOTATATE and 18F-FDG PET/CT for staging or restaging purposes. Detailed clinical data, including common cardiovascular risk factors, were recorded. For a separate assessment, they were divided into a high-risk and a low-risk group. In each patient, we calculated the maximum target-to-background ratio (TBR) of eight arterial segments. The correlation of the TBRmean of both tracers with risk factors including plaque burden was assessed. RESULTS: The mean TBR of 68Ga-DOTATATE in all large arteries correlated significantly with the presence of CPs (r = 0.52; p < 0.05), hypertension (r = 0.60; p < 0.05), age (r = 0.56; p < 0.05), and uptake of 18F-FDG (r = 0.64; p < 0.01). There was one significant correlation between 18F-FDG uptake and hypertension (0.58; p < 0.05). Out of the 37 sites with the highest focal 68Ga-DOTATATE uptake, 16 (43.2%) also had focal 18F-FDG uptake. Of 39 sites with the highest 18F-FDG uptake, only 11 (28.2%) had a colocalized 68Ga-DOTATATE accumulation. CONCLUSIONS: In this series of cancer patients, we found a stronger association of increased 68Ga-DOTATATE uptake with known risk factors of cardiovascular disease as compared to 18F-FDG, suggesting a potential role for plaque imaging in large arteries. Strikingly, we found that focal uptake of 68Ga-DOTATATE and 18F-FDG does not colocalize in a significant number of lesions.
背景:Ga-[1,4,7,10-四氮杂环十二烷-N,N',N″,N'″-四乙酸]-D-Phe1,Tyr3-奥曲肽(DOTATATE)正电子发射断层扫描(PET)常用于可视化生长抑素受体(SSTR)阳性神经内分泌肿瘤。SSTR 也已知在巨噬细胞上表达,巨噬细胞在冠状动脉和大血管壁的炎症过程中发挥主要作用。因此,成像 SSTR 表达有可能可视化易损斑块。我们评估了 68Ga-DOTATATE 在大血管中的积聚与 18F-2-氟脱氧葡萄糖(FDG)摄取、钙化斑块(CPs)和心血管危险因素的关系。
方法:16 例连续的神经内分泌肿瘤或甲状腺癌患者接受了 68Ga-DOTATATE 和 18F-FDG PET/CT 分期或重新分期。记录了详细的临床数据,包括常见的心血管危险因素。为了单独评估,他们被分为高风险组和低风险组。在每个患者中,我们计算了八个动脉节段的最大靶标与背景比(TBR)。评估了两种示踪剂的 TBRmean 与包括斑块负担在内的危险因素的相关性。
结果:所有大动脉的 68Ga-DOTATATE 平均 TBR 与 CPs 的存在呈显著相关(r=0.52;p<0.05)、高血压(r=0.60;p<0.05)、年龄(r=0.56;p<0.05)和 18F-FDG 摄取(r=0.64;p<0.01)。18F-FDG 摄取与高血压之间存在唯一显著相关性(0.58;p<0.05)。在 68Ga-DOTATATE 摄取最高的 37 个部位中,有 16 个(43.2%)也有 18F-FDG 摄取。在 18F-FDG 摄取最高的 39 个部位中,只有 11 个(28.2%)有 68Ga-DOTATATE 的聚集。
结论:在这一系列癌症患者中,我们发现与心血管疾病已知危险因素相比,68Ga-DOTATATE 摄取的增加与 18F-FDG 有更强的关联,这表明在大动脉中斑块成像可能具有潜在作用。引人注目的是,我们发现 68Ga-DOTATATE 和 18F-FDG 的局灶性摄取在大量病变中没有明显的聚集。
2025-1
Medicine (Baltimore). 2023-5-12
Eur Heart J Cardiovasc Imaging. 2025-3-3
Front Cardiovasc Med. 2024-9-12
PLoS One. 2024
Nat Rev Cardiol. 2024-9
Arthritis Res Ther. 2024-1-16
Eur J Nucl Med Mol Imaging. 2024-1
J Nucl Cardiol. 2023-12
Eur J Nucl Med Mol Imaging. 2009-10